Brian D. Lee - Search Results

Year	Number of Results
2003	2
2004	1
2006	1
2007	1
2012	2
2013	1
2014	1
2015	1
2016	1
2017	1
2018	1
2022	0

1

Tumor necrosis factor alpha inhibitors in the treatment of toxic epidermal necrolysis.

Woolridge KF, Boler PL, Lee BD. Woolridge KF, et al. Among authors: lee bd. Cutis. 2018 Jan;101(1):E15-E21. Cutis. 2018. PMID: 29529123 Review.

2

Land cover diversity increases predator aggregation and consumption of prey.

Penn HJ, Athey KJ, Lee BD. Penn HJ, et al. Among authors: lee bd. Ecol Lett. 2017 May;20(5):609-618. doi: 10.1111/ele.12759. Epub 2017 Mar 28. Ecol Lett. 2017. PMID: 28370953

3

Bullous pilomatricoma: a rarely reported variant of pilomatricoma.

DiGiorgio CM, Kaskas NM, Matherne RJ, Shannon AB, Lee BD. DiGiorgio CM, et al. Among authors: lee bd. Dermatol Online J. 2015 Sep 17;21(9):13030/qt4g99b171. Dermatol Online J. 2015. PMID: 26437288

4

Preclinical assessment of a zwitterionic tantalum oxide nanoparticle X-ray contrast agent.

Bonitatibus PJ Jr, Torres AS, Kandapallil B, Lee BD, Goddard GD, Colborn RE, Marino ME. Bonitatibus PJ Jr, et al. Among authors: lee bd. ACS Nano. 2012 Aug 28;6(8):6650-8. doi: 10.1021/nn300928g. Epub 2012 Jul 25. ACS Nano. 2012. PMID: 22768795

5

Evaluation of the novel USPIO GEH121333 for MR imaging of cancer immune responses.

Shi Q, Pisani LJ, Lee YK, Messing S, Ansari C, Bhaumik S, Lowery L, Lee BD, Meyer DE, Daldrup-Link HE. Shi Q, et al. Among authors: lee bd. Contrast Media Mol Imaging. 2013 May-Jun;8(3):281-8. doi: 10.1002/cmmi.1526. Contrast Media Mol Imaging. 2013. PMID: 23606432 Free PMC article.

6

Biological performance of a size-fractionated core-shell tantalum oxide nanoparticle x-ray contrast agent.

Torres AS, Bonitatibus PJ Jr, Colborn RE, Goddard GD, FitzGerald PF, Lee BD, Marino ME. Torres AS, et al. Among authors: lee bd. Invest Radiol. 2012 Oct;47(10):578-87. doi: 10.1097/RLI.0b013e318260fc40. Invest Radiol. 2012. PMID: 22836312

7

Synthesis and evaluation of dihydropyrroloquinolines that selectively antagonize P-glycoprotein.

Lee BD, Li Z, French KJ, Zhuang Y, Xia Z, Smith CD. Lee BD, et al. J Med Chem. 2004 Mar 11;47(6):1413-22. doi: 10.1021/jm0303204. J Med Chem. 2004. PMID: 14998330

8

Discovery and evaluation of inhibitors of human sphingosine kinase.

French KJ, Schrecengost RS, Lee BD, Zhuang Y, Smith SN, Eberly JL, Yun JK, Smith CD. French KJ, et al. Among authors: lee bd. Cancer Res. 2003 Sep 15;63(18):5962-9. Cancer Res. 2003. PMID: 14522923

9

A Proposed Computed Tomography Contrast Agent Using Carboxybetaine Zwitterionic Tantalum Oxide Nanoparticles: Imaging, Biological, and Physicochemical Performance.

FitzGerald PF, Butts MD, Roberts JC, Colborn RE, Torres AS, Lee BD, Yeh BM, Bonitatibus PJ Jr. FitzGerald PF, et al. Among authors: lee bd. Invest Radiol. 2016 Dec;51(12):786-796. doi: 10.1097/RLI.0000000000000279. Invest Radiol. 2016. PMID: 27115702 Free PMC article.

10

Development of a syngeneic in vivo tumor model and its use in evaluating a novel P-glycoprotein modulator, PGP-4008.

Lee BD, French KJ, Zhuang Y, Smith CD. Lee BD, et al. Oncol Res. 2003;14(1):49-60. doi: 10.3727/000000003108748603. Oncol Res. 2003. PMID: 14552591

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results